HomeIOVA • NASDAQ
add
Iovance Biotherapeutics Inc
Previous close
$3.30
Day range
$3.21 - $3.45
Year range
$2.70 - $14.23
Market cap
1.12B USD
Avg Volume
10.14M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 73.69M | 15,189.21% |
Operating expense | 114.73M | -2.25% |
Net income | -78.56M | 32.50% |
Net profit margin | -106.60 | 99.56% |
Earnings per share | -0.26 | 42.22% |
EBITDA | -78.06M | 31.77% |
Effective tax rate | -2.02% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 323.78M | 15.69% |
Total assets | 910.43M | 16.67% |
Total liabilities | 200.02M | 2.19% |
Total equity | 710.40M | — |
Shares outstanding | 327.88M | — |
Price to book | 1.42 | — |
Return on assets | -22.76% | — |
Return on capital | -26.70% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -78.56M | 32.50% |
Cash from operations | -73.30M | 12.71% |
Cash from investing | 23.68M | 132.50% |
Cash from financing | 2.31M | 140.02% |
Net change in cash | -48.49M | 68.27% |
Free cash flow | -44.82M | -12.25% |
About
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
Founded
2007
Headquarters
Website
Employees
838
